Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Genentech describes von Hippel-Lindau disease tumor suppressor inhibitors

June 7, 2022

Chinese investigators patent new HIF inhibitors

May 13, 2022

Zhejiang Hisun Pharmaceutical, Hisun Accuray Therapeutics patent anticoagulants

April 12, 2022

New NFE2-related factor 2 activators described by Sanofi

April 1, 2022

Procoagulant nanoparticles as platelet surrogates for management of bleeding

March 4, 2022

China Hinye Pharmaceutical presents prodrugs of the active metabolite of clopidogrel

Feb. 28, 2022

Microlyse targets VWF and clears microvascular thrombosis

Feb. 23, 2022

New coagulation factor XIa inhibitors synthesized at Janssen Pharmaceutica

Feb. 18, 2022

HMB-001 bispecific antibody shows promise for treating Glanzmann thrombasthenia

Feb. 15, 2022

Janssen Pharmaceutica presents new factor XIa inhibitors

Feb. 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...